Sale by Larochelle Karen of 335 shares of PaxMedica
PXMDDelisted Stock | USD 0.86 0.18 17.31% |
About 62% of PaxMedica, Common's investor base is looking to short. The analysis of overall sentiment of trading PaxMedica, Common Stock pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with PaxMedica, Common's historical and current headlines, can help investors time the market. In addition, many technical investors use PaxMedica, Common Stock stock news signals to limit their universe of possible portfolio assets.
PaxMedica, Common pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of PaxMedica, daily returns and investor perception about the current price of PaxMedica, Common Stock as well as its diversification or hedging effects on your existing portfolios.
PaxMedica, |
Filed transaction by Paxmedica Inc director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
PaxMedica, Common Fundamental Analysis
We analyze PaxMedica, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PaxMedica, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PaxMedica, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
PaxMedica, Common is currently under evaluation in target price category among its peers.
PaxMedica, Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PaxMedica, Common pink sheet to make a market-neutral strategy. Peer analysis of PaxMedica, Common could also be used in its relative valuation, which is a method of valuing PaxMedica, Common by comparing valuation metrics with similar companies.
Peers
PaxMedica, Common Related Equities
REVB | Revelation Biosciences | 25.00 | ||||
UNCY | Unicycive Therapeutics | 7.25 | ||||
QNRX | Quoin Pharmaceuticals | 6.67 | ||||
KPRX | Kiora Pharmaceuticals | 5.52 | ||||
BDRX | Biodexa Pharmaceticals | 4.09 | ||||
VRAX | Virax Biolabs | 1.02 | ||||
ALLR | Allarity Therapeutics | 1.82 | ||||
PALI | Palisade Bio | 2.44 | ||||
CDIO | Cardio Diagnostics | 3.23 | ||||
ZVSA | ZyVersa Therapeutics | 3.74 | ||||
IMMX | Immix Biopharma | 4.74 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in PaxMedica, Pink Sheet
If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |